Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
GH Research Logo
GH Research Growth Score
49
CB Rank
8267
Heat Score
69
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Founded
obfuscation
PublicPost-IPO Equity Dublin, Dublin, Ireland51-100 www.ghres.com/
Biopharma
Biotechnology
Pharmaceutical
Overview

GH Research
Total Funding
obfuscation
Growth Score
49
Heat Score
69

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score49
-13 pts
in past quarter
Heat Score 69
11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About GH Research

CB Rank
8267
GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.
Founded
obfuscation
PublicPost-IPO Equity Dublin, Dublin, Ireland51-100 www.ghres.com/
Biopharma
Biotechnology
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Series B
OBF
in
obfuscation

Key People

Details

Legal Name GH Research Plc
Operating Status Active
Stock Symbol  NASDAQ:GHRS
Company Type For Profit
Founders  Florian Schonharting, Theis Terwey
About the Company
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.
Contact Email info@ghres.com
Predictions & Insights

Growth Insight

See this Growth Insight
GH Research is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

GH001
A mebufotenin-based inhalation therapy currently in Phase 2b trials for treatment-resistant depression, and Phase 2a trials for bipolar II disorder and postpartum depression.
GH002
A mebufotenin-based intravenous therapy that has completed Phase 1 trials for psychiatric or neurological disorders.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity
obfuscation
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
3
obfuscation
Lynx1 Capital ManagementPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Lynx1 Capital Management Logo
Lynx1 Capital Management
Yes
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
—
Lynx1 Capital Management Logo
Lynx1 Capital Management
Yes
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
—
Lynx1 Capital Management Logo
Lynx1 Capital Management
Yes
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
—
Lynx1 Capital Management Logo
Lynx1 Capital Management
Yes
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
—
Lynx1 Capital Management Logo
Lynx1 Capital Management
Yes
Post-IPO Equity - GH Research Logo
Post-IPO Equity - GH Research
—
Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 3 Contacts 18

Employee Profiles

News

News and Press

News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 14, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 30, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,030
203.44%
 in past month

IT Spend

$967.9KThis year, GH Research is projected to spend $967.9K on IT, according to Aberdeen.

Active Website Tech Count

20GH Research is actively using 20 technologies for its website, according to BuiltWith. These include DNSSEC, IPv6, and  CommonCrawl Top 5m.

Total IP

4The intellectual property of GH Research includes 4 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is GH Research's headquarters? GH Research is located in Dublin, Dublin, Ireland.Who invested in GH Research? GH Research has 14 investors including Lynx1 Capital Management and  Deep Track Capital.When was the last funding round for GH Research? GH Research closed its last funding round on
obfuscation
from a Post-IPO Equity round.How much funding has GH Research raised to date? GH Research has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|